Type III secretion gets an LcrV tip
1Centre for Molecular Microbiology and Infection, Imperial College London, Flowers Building, Armstrong Road, London, UK, SW7 2AZ. j.mota@imperial.ac.uk
Abstract:
Type III secretion is used by many Gram-negative pathogenic bacteria to inject effector proteins into eukaryotic host cells. Effector delivery requires a secretion apparatus, called an injectisome or needle complex, and the assembly of a translocation pore in a target-cell membrane. Recent work provides evidence that enlightens the view of how pore assembly might occur and of how the injectisome and the pore might be linked.
More Related Videos
09:05High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability
Published on: November 21, 2014
14:05Imaging InlC Secretion to Investigate Cellular Infection by the Bacterial Pathogen Listeria monocytogenes
Published on: September 19, 2013
Related Concept Videos
Gram-negative Bacterial Protein Secretion Systems
Mechanism of Conjugation
Regulation of Bacterial Virulence
Pinching-off of Coated Vesicles
Bacterial Translocation and Protein Secretion
Plague
